Glenmark
FDA greenlights Glenmark’s generic version of Biogen’s Tecfidera in relapsing multiple sclerosis
October 7, 2020Research and Development, Sales and Marketing Biogen, Glenmark, generic, multiple sclerosis
Glenmark Pharma will be celebrating after it secured FDA approval in the US to market dimethyl fumarate, a generic version …
FDA approves Glenmark’s generic version of Novartis’ Exjade tablets for chronic iron overload
January 7, 2020Manufacturing and Production, Research and Development Glenmark, exjade, generic, pharma
Indian pharma firm Glenmark has announced it has secured approval from the FDA for its oral deferasirox tablets in the …
FDA knocks back Glenmark’s allergic rhinitis therapy Ryaltris
June 25, 2019Manufacturing and Production, Sales and Marketing FDA, Glenmark, Ryaltris, US, allergy, pharma
Stocks in Indian pharmaceutical firm Glenmark were sent plummeting to a six-year low after it was confirmed that the FDA …
Glenmark signs deal with Novartis over distribution in Brazil
June 24, 2019Sales and Marketing Brazil, Glenmark, Latin America, Novartis, distribution, pharma
Indian firm Glenmark Pharmaceuticals has entered into an agreement with Novartis over the distribution of its respiratory products in Brazil. …
FDA approves first generic versions of Lilly’s ADHD drug
May 31, 2017Research and Development, Sales and Marketing ADHD, Apotex, Aurobindo, FDA, Glenmark, Teva
The FDA has given its approval for the commercialisation of the first-ever generic versions of Eli Lilly’s Strattera (atomoxetine) for …
Glenmark greenlighted to market hypertension generic in US
May 30, 2017Manufacturing and Production, Sales and Marketing FDA, Glenmark, generic, hypertension
Glenmark Pharmaceuticals has revealed it has been awarded final approval by the FDA to market hypertension treatment nebivolol, a generic …
Sanofi strikes Crohn’s deal with Glenmark
May 16, 2011Research and Development Crohn’s disease, Glenmark, Sanofi
Sanofi has signed a deal with Indian drug maker Glenmark Pharmaceuticals to develop a new treatment for Crohn’s Disease. The …
Sanofi signs Indian pain drug development deal
May 5, 2010Research and Development Glenmark, Sanofi-Aventis, chronic pain, pain therapeutics
Sanofi-Aventis has signed an agreement with Indian firm Glenmark Pharmaceuticals to develop novel agents for the treatment of chronic pain. …
